Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma

Despite intensive research efforts, pancreatic ductal adenocarcinoma is still regarded as an aggressive and life-limiting malignancy. Combination chemotherapy regimens that underpin the current treatment approach in the advanced setting have led to incremental survival gains in recent years but have...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Caroline Y. K., Burke, Emma, Cunningham, David, Starling, Naureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748185/
https://www.ncbi.nlm.nih.gov/pubmed/31582971
http://dx.doi.org/10.1155/2019/7135437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748185/
https://www.ncbi.nlm.nih.gov/pubmed/31582971
http://dx.doi.org/10.1155/2019/7135437

Ejemplares similares